NS. Scott Gottlieb told CNBC that the omicron variant “expands the timeline” at a time when Covid will transition from a health emergency to something the world learns to live with.
“I still think this is going to be a transition year,” Gottlieb said Tuesday night on “News with Shepard Smith“It is likely that we will “go from a pandemic to a more endemic phase” but later.
However, on Wednesday morning, Pfizer said its own research had shown that the third shot of the Covid vaccine neutralizes omicrons.
In the wake of that news, Gottlieb said the best thing to do is vaccinate and boost, “hopefully three doses of the vaccine will be enough protection” as the booster “acts like infected.”
Gottlieb, a current board member of Covid vaccine maker Pfizer, told Shepard Smith he made that prediction when he said delta was the most worrying variant. However, the doctor said the omicron represents a “different evolution” of Covid, and that could warn the trajectory of its spread in the US and around the world “even after the population is more likely to immunity from infection.”
That’s probably what’s happening right now in South Africa, said Gottlieb, who led the Food and Drug Administration during the former president’s era. Donald Trumptime in office.
“The reason why you see less severe illness and fewer hospital admissions than cases is that a lot of people in South Africa have had delta,” he said. “So when they get reinfected with this variant, it’s possible that their delta immunity doesn’t protect against infection but protects them against symptomatic disease and serious outcomes.”
Pfizer CEO Albert Bourla said Third, the omicron appears to be milder, but it can also spread faster, creating more opportunity for later variants to develop.
The South African Medical Research Council said on Saturday that most patients hospitalized with the new variant do not require supplemental oxygen. Dr. Anthony Fauci, chief medical adviser to the White House said preliminary data like this is “a little encouragement.”
Disclosure: Scott Gottlieb is a CNBC contributor and board member of Pfizer, genetic testing startup Tempus, healthcare technology company Aetion, and biotech company Illumina. He is also the co-chair of Norwegian Cruise Line Holdings‘ and Royal Caribbean“The Healthy Sail Dashboard.”
https://www.cnbc.com/2021/12/08/dr-scott-gottlieb-omicron-may-extend-pandemic-still-sees-transition-year-ahead.html Omicron can extend pandemic, still ‘transition year’ ahead